Clinical Trials Directory

Trials / Unknown

UnknownNCT04518020

Single Crown Supported by Short Implant Versus Standard Implant in Conjunction With Maxillary Sinus Floor Augmentation.

Single Crown Supported by Short Implant Versus Standard Implant in Conjunction With Maxillary Sinus Floor Augmentation in the Posterior: a Randomized, Controlled Clinical Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Aalborg University Hospital · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

Implant placement in the posterior part of the maxilla is frequently compromised due to atrophy of the alveolar process. Therefore, alveolar ridge augmentation is frequently necessary before or in conjunction with implant placement. The most commonly used method to augment the maxillary premolar and molar region involves the maxillary sinus floor augmentation (MSFA) with autogenous bone graft or a bone substitute. However, the use of autogenous bone grafts is associated with risk at the donor site morbidity and unpredictable graft resorption. Consequently, short implants are used increasingly to eliminate the need for bone augmentation. However, long-term studies comparing short implants and standard implants in conjunction with MSFA supporting single crown restoration in the posterior maxilla are missing. The primary outcome measures include survival of implant and suprastructures, peri-implant marginal bone level (MBL), professional evaluation of the suprastructure and soft tissue using pink esthetic score (PES) and white esthetic score (WES), patient satisfaction using visual analogue scale (VAS), and oral health related quality of life using oral health impact profile (OHIP-14) questionnaire. Secondary outcome measure include evaluation of the complication rate related to the two treatment modalities.

Detailed description

The primary objective of the present study is to test the H0 hypothesis of: 1. No differences in survival of suprastructures and implants with the two treatment modalities. 2. No differences in peri-implant MBL, PES, WES, and patient satisfaction using VAS with the two treat modalities. 3. No differences in oral health related quality of life using OHIP-14 with the two treatment modalities. The secondary objective will include: 1\. Complications related to bone harvesting, implant installation, and MSFA. The primary outcome measures included: * Survival of suprastructures. * Survival of implants. * Radiographic peri-implant MBL. * Professional evaluation of suprastructure and soft tissue using PES and WES. * Patient satisfaction using VAS * Oral health related quality of life using OHIP-14 questionnaire. Secondary outcome measures: • Pre- and postoperative complications.

Conditions

Interventions

TypeNameDescription
PROCEDURE40 patients will be randomly allocated to short implants and standard implants in conjunction with MSFA40 patients will be randomly allocated to short implants (group 1) and standard implants in conjunction with MSFA using 50% particulated autogenous mandibular bone graft mixed with 50% Bio-Oss (group 2).

Timeline

Start date
2016-11-16
Primary completion
2021-07-01
Completion
2025-07-01
First posted
2020-08-19
Last updated
2022-07-20

Source: ClinicalTrials.gov record NCT04518020. Inclusion in this directory is not an endorsement.